Association of adipose tissue activity in cervical regions with weight loss and prognostic survival in gastric cancer patients.
2/5 보강
TL;DR
In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
310 patients diagnosed with gastric cancer.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis. This study could provide valuable insights into the pathophysiology of cachexia and potentially support the development of targeted therapeutic interventions.
OpenAlex 토픽 ·
Nutrition and Health in Aging
Adipokines, Inflammation, and Metabolic Diseases
Muscle Physiology and Disorders
In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable surviv
- p-value p < 0.05
- HR 1.81
APA
Jun Han, Diya Sun, et al. (2026). Association of adipose tissue activity in cervical regions with weight loss and prognostic survival in gastric cancer patients.. Clinical nutrition ESPEN, 72, 102901. https://doi.org/10.1016/j.clnesp.2025.102901
MLA
Jun Han, et al.. "Association of adipose tissue activity in cervical regions with weight loss and prognostic survival in gastric cancer patients.." Clinical nutrition ESPEN, vol. 72, 2026, pp. 102901.
PMID
41525873 ↗
Abstract 한글 요약
[BACKGROUND] With the application of positron emission tomography-computed tomography (PET-CT) in recent years, studies have found that brown adipose tissue is not only present in infants and hibernating mammals but also persists in the neck regions of adults. Cancer-associated cachexia, a complex metabolic syndrome, is characterized by adipose tissue loss and heightened metabolic activity. Despite the profound impact of cachexia on patient outcomes, research into the metabolic dynamics of brown adipose tissue has been sparse. The objective of this study is to quantify the metabolic activity of adipose tissue in the neck regions of gastric cancer patients using PET-CT and to elucidate the relationship between adipose tissue metabolic activity and cachexia, along with its potential predictive value for survival outcomes.
[METHODS] We collected PET-CT imaging data and 18F-fluorodeoxyglucose (FDG) standardized uptake values from the nuchal adipose tissue of 310 patients diagnosed with gastric cancer. Concurrently, we gathered clinical data from these patients to facilitate a thorough analysis. The t-test was employed to evaluate the FDG uptake differences in nuchal adipose tissue between gastric cancer patients exhibiting cancer cachexia or not. The correlation between FDG uptake of nuchal adipose tissue and clinical indicators, along with weight loss and nutritional status, was further analyzed using Spearman's rank correlation test. Kaplan-Meier curves and Cox Proportional Hazards Model were employed to clarify the survival of gastric cancer patients in different FDG uptake groups.
[RESULTS] The 310 gastric cancer patients were divided into 103 patients with cachexia and 207 patients without cachexia. Patients with cachexia exhibited a significantly elevated FDG uptake of nuchal adipose tissue compared to those without cachexia (p < 0.05). Furthermore, correlation analyses demonstrated notable inverse relationships between the FDG uptake of nuchal adipose tissue with body mass index and serum albumin concentrations (p < 0.05). We also observed a positive correlation between the FDG uptake of nuchal adipose tissue with both the weight loss ratio and serum concentrations of tumor necrosis factor-alpha (all p < 0.05). Additionally, patients with elevated FDG uptake of nuchal adipose tissue had a significantly lower survival rate compared to those with lower FDG uptake (p = 0.04). Furthermore, FDG uptake in nuchal adipose tissue was an independent prognostic indicator in gastric cancer patients (HR = 1.81, p = 0.03).
[CONCLUSIONS] In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis. This study could provide valuable insights into the pathophysiology of cachexia and potentially support the development of targeted therapeutic interventions.
[METHODS] We collected PET-CT imaging data and 18F-fluorodeoxyglucose (FDG) standardized uptake values from the nuchal adipose tissue of 310 patients diagnosed with gastric cancer. Concurrently, we gathered clinical data from these patients to facilitate a thorough analysis. The t-test was employed to evaluate the FDG uptake differences in nuchal adipose tissue between gastric cancer patients exhibiting cancer cachexia or not. The correlation between FDG uptake of nuchal adipose tissue and clinical indicators, along with weight loss and nutritional status, was further analyzed using Spearman's rank correlation test. Kaplan-Meier curves and Cox Proportional Hazards Model were employed to clarify the survival of gastric cancer patients in different FDG uptake groups.
[RESULTS] The 310 gastric cancer patients were divided into 103 patients with cachexia and 207 patients without cachexia. Patients with cachexia exhibited a significantly elevated FDG uptake of nuchal adipose tissue compared to those without cachexia (p < 0.05). Furthermore, correlation analyses demonstrated notable inverse relationships between the FDG uptake of nuchal adipose tissue with body mass index and serum albumin concentrations (p < 0.05). We also observed a positive correlation between the FDG uptake of nuchal adipose tissue with both the weight loss ratio and serum concentrations of tumor necrosis factor-alpha (all p < 0.05). Additionally, patients with elevated FDG uptake of nuchal adipose tissue had a significantly lower survival rate compared to those with lower FDG uptake (p = 0.04). Furthermore, FDG uptake in nuchal adipose tissue was an independent prognostic indicator in gastric cancer patients (HR = 1.81, p = 0.03).
[CONCLUSIONS] In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis. This study could provide valuable insights into the pathophysiology of cachexia and potentially support the development of targeted therapeutic interventions.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study.
- Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive-stage small cell lung cancer.
- Letter to the Editor: Yttrium-90 superiority in hepatocellular carcinoma downstaging-Treatment effect or selection bias?
- Diagnostic Dilemma of Milky Yellow Pleural Effusion.
- [Effects of TEAS and acupoint pressing on the quality of life of breast cancer patients during perioperative chemotherapy: a randomized controlled trial].
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.